Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global
biochemical profile and provide a novel metabolism-related target to improve the therapeutic …

LMP1, which is encoded by the Epstein-Barr virus, is proposed to be one of the major
oncogenic factors involved in nasopharyngeal carcinoma (NPC). Previous studies …

Non‐keratinizing nasopharyngeal carcinoma (NPC) is closely associated with Epstein–Barr
virus (EBV) infection. The EBV‐encoded latent membrane protein 1 (LMP1) is believed to …

EBV infection of preinvasive nasopharyngeal epithelium is believed to be an initiation step
during pathogenesis of nasopharyngeal carcinoma (NPC), but the mechanisms remain …

Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV)
infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The …

Myeloid-derived suppressor cells (MDSCs) are expanded in tumor microenvironments,
including that of Epstein–Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) …

Emerging evidence confirms that cancer stem cells (CSCs) are responsible for the
chemoradioresistance of malignancies. EBV-encoded latent membrane protein 1 (LMP1) is …

To establish persistent infection in cells, viruses evolve strategies to alter host cellular
pathways to regulate cell proliferation and energy metabolism which support viral infection …

We conducted this research to explore the role of latent membrane protein 1 (LMP1)
encoded by the Epstein–Barr virus (EBV) in modulating the DNA damage response (DDR) …

Accumulating evidence indicates that oncogenic viral protein plays a crucial role in
activating aerobic glycolysis during tumorigenesis, but the underlying mechanisms are …